The withdrawal of SU is also aligned with the Italian Standards for the Treatment of Diabetes Mellitus, which discourages use of SU/glinides upon initiation of BI.18 Finally, the titration algorithm appears smoother and safer in ITAS vs that of TAKE CONTROL, with smaller insulin dose changes targeting safer glycaemic targets.13 Here, INS is linked to diabetes mellitus.